Vaccine & Biologics Process Development, Merck & Corporation, Inc, West Point, Pennsylvania 19486, USA.
J Pharm Sci. 2011 Jun;100(6):2120-35. doi: 10.1002/jps.22450. Epub 2011 Jan 6.
Global aggregation behaviors of three distinct monoclonal antibodies were characterized by high throughput, multiassay analysis. First, extensive screening of formulations was performed using both incubation at elevated temperature and differential thermal scanning. In incubation studies, formulation conditions representing native favored, native favored but with particulate formation, unfolding with slow aggregation, and fast aggregation with or without phase separation were mapped across a wide range of pH and ionic strength. The sample types or aggregation kinetic scenarios were classified based on fluorescence spectroscopy, light scattering, and micron particle count. Furthermore, apparent melting point was determined for each formulation condition by differential thermal scanning. The global aggregation behaviors and their apparent melting points together highlight the common underlying aggregation pathways and kinetics for the three antibodies. Overall, incorporating multistage aggregation mechanisms in multivariate data analysis provides valuable insights to what and how high throughput techniques can be implemented. Understanding global aggregation behaviors is a key element toward development of rational screening approach.
通过高通量、多分析物分析,研究人员对三种不同单克隆抗体的全局聚集行为进行了表征。首先,通过高温孵育和差示扫描量热法对制剂进行了广泛筛选。在孵育研究中,根据荧光光谱、光散射和微米颗粒计数,将代表天然有利、天然有利但有颗粒形成、缓慢聚集时展开、快速聚集且有或无相分离的制剂条件映射到很宽的 pH 和离子强度范围内。此外,通过差示扫描量热法确定了每种制剂条件的表观熔点。全局聚集行为及其表观熔点共同突出了三种抗体的常见聚集途径和动力学。总的来说,在多元数据分析中纳入多阶段聚集机制提供了有价值的见解,即了解高通量技术可以如何以及在哪些方面得到实施。理解全局聚集行为是开发合理筛选方法的关键要素。